申请人:——
公开号:US20020193410A1
公开(公告)日:2002-12-19
This invention is directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans that inhibit Factor Xa, pharmaceutical compositions comprising these compounds and their use for inhibiting Factor Xa or treating pathological conditions in a patient that may be ameliorated by administration of such compounds. This invention is also is also directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans which directly inhibit both Factor Xa and Factor IIa (thrombin), to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of simultaneously directly inhibiting both Factor Xa and Factor IIa (thrombin).
这项发明涉及取代的(氨基亚甲基或氨甲基)二氢苯并呋喃和苯并吡喃,这些化合物抑制因子Xa,包括这些化合物的药物组合物以及它们用于抑制因子Xa或治疗可以通过给予这些化合物改善的患者的病理状况。这项发明还涉及取代的(氨基亚甲基或氨甲基)二氢苯并呋喃和苯并吡喃,直接抑制因子Xa和因子IIa(凝血酶),包括这些化合物的药物组合物,用于制备这些化合物的中间体,以及同时直接抑制因子Xa和因子IIa(凝血酶)的方法。